EFFICACY OF ORAL N-ACETYLCYSTEINE IN THE MANAGEMENT OF SEVERE ACETAMINOPHEN -INDUCEDHEPATOXICITY: A CASE REPORT
Oral NAC in Severe Acetaminophen Toxicity
Abstract
Introduction: Acetaminophen poisoning is a leading cause of acute toxic liver injury worldwide and requires rapid recognition and timely antidotal therapy. Objective: To present a case of intentional acetaminophen overdose and highlight urgent management with N-acetylcysteine (NAC), with discussion of indications for escalation to renal replacement therapy. Case Presentation: A 19-year-old male presented 12 hours after intentional ingestion of approximately 50 g of acetaminophen (100 tablets of 500 mg). Oral NAC was initiated 9 hours post-ingestion at a regional hospital following toxicology consultation. On admission, laboratory evaluation demonstrated evolving acute hepatic injury with peak transaminases at 36–48 hours (AST 2358.6 U/L, ALT 3807 U/L), INR 1.91, and mild hyperbilirubinemia, while renal function remained preserved. Arterial blood gas analysis showed no severe metabolic acidosis, and serum creatinine remained within reference ranges throughout hospitalization. Serial monitoring revealed gradual normalization of coagulation parameters and liver enzymes, with ALT returning to normal by 70 hours. Supportive care and continuation of NAC resulted in complete clinical recovery without progression to acute liver failure. Conclusion: Early administration of NAC remains the cornerstone of acetaminophen toxicity management and is sufficient in most cases. Renal replacement therapy should be reserved for massive ingestions or patients with severe acidosis or deterioration despite antidotal therapy, recognizing challenges related to dialyzability of NAC and the need for dose adjustment.
Key words: Acetaminophen, poisoning, N-acetyl cysteine, NAC, Antidotes, Chemical and Drug Induced Liver Injury, Administration Oral, Liver Regeneration.
References
2. Kouznetsov VV. Exploring acetaminophen prodrugs and hybrids: a review. RSC Adv. 2024;14(14):9691-9715. doi:10.1039/D4RA00365A. https://pubs.rsc.org/en/content/articlelanding/2024/ra/d4ra00365a
3. Ramachandran A, Jaeschke H. Acetaminophen Toxicity: Novel Insights Into Mechanisms and Future Perspectives. Gene Expr. 2018 Mar 21;18(1):19-30. doi:10.3727/105221617X15084371374138.
4. Bateman DN, Dear JW. Acetylcysteine in paracetamol poisoning: a perspective of 45 years of use. Toxicol Res (Camb). 2019;8(4):489-498. doi:10.1039/C9TX00002J. https://pubmed.ncbi.nlm.nih.gov/29054140/
5. Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update. J Clin Transl Hepatol. 2016 Jun 28;4(2). doi:10.14218/JCTH.2015.00052. https://pubmed.ncbi.nlm.nih.gov/27350943/
6. Hendrickson RG. What is the most appropriate dose of N-acetylcysteine after massive acetaminophen overdose? Clin Toxicol. 2019 Aug 3;57(8):686-691. doi:10.1080/15563650.2019.1579914.
7. Walczewska S, Wawrzyniak A. N-acetylcysteine in clinical practice - properties, use and adverse effects. Pediatria i Medycyna Rodzinna. 2020 Oct 30;16(3):243-246. doi:10.15557/PiMR.2020.0044. https://pubmed.ncbi.nlm.nih.gov/30777470/
8. Rumack BH. Acetylcysteine Treatment of Acetaminophen Overdose: Foundational and Clinical Development. Livers. 2025 Apr 25;5(2):20. doi:10.3390/livers5020020.
9. Rahimi M, Shadnia S, Mostafazadeh B, Evini PET, Hosseini SM, Deravi N, et al. Acetaminophen Poisoning: Case Reports of Early Liver Dialysis for Hepatic Injury. Clin Case Rep. 2025 Jul 17;13(7). doi:10.1002/ccr3.70642.
10. Santus P, Signorello JC, Danzo F, Lazzaroni G, Saad M, Radovanovic D. Anti-Inflammatory and Anti-Oxidant Properties of N-Acetylcysteine: A Fresh Perspective. J Clin Med. 2024 Jul 15;13(14):4127. doi:10.3390/jcm13144127. https://pubmed.ncbi.nlm.nih.gov/39064168/
11. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose. N Engl J Med. 1988 Dec 15;319(24):1557-1562. doi:10.1056/NEJM198812153192401.
12. Yarema MC, Johnson DW, Berlin RJ, Sivilotti MLA, Nettel-Aguirre A, Brant RF, et al. Comparison of the 20-Hour Intravenous and 72-Hour Oral Acetylcysteine Protocols for the Treatment of Acute Acetaminophen Poisoning. Ann Emerg Med. 2009 Oct;54(4):606-614. doi:10.1016/j.annemergmed.2009.05.010. https://pubmed.ncbi.nlm.nih.gov/3059186/
13. Hall B, Wilson K, Blind F. Clinical Progress Note: Goal-Directed N-acetylcysteine Treatment of Acetaminophen Toxicity. J Hosp Med. 2021 Jun 19;16(6):361-363. doi:10.12788/jhm.3447.
14. Licata A, Minissale MG, Stankeviciute S, Sanabria-Cabrera J, Lucena MI, Andrade RJ, et al. N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review. Front Pharmacol. 2022 Aug 10;13. doi:10.3389/fphar.2022.828565.
15. Chiu MH, Jaworska N, Li NL, Yarema M. Massive Acetaminophen Overdose Treated Successfully with N-Acetylcysteine, Fomepizole, and Hemodialysis. Case Rep Crit Care. 2021 Jul 11;2021:1-5. doi:10.1155/2021/6695967. https://pubmed.ncbi.nlm.nih.gov/34336301/
16. Tjajadi M. Extracorporeal Treatment For Acetaminophen Poisoning: Recommendations from the EXTRIP Workgroup. J Emerg Med. 2014 Dec;47(6):751-752. doi:10.1016/j.jemermed.2014.10.013. https://www.jem-journal.com/article/S0736-4679(14)01206-2/abstract
17. Ghannoum M, Kazim S, Grunbaum AM, Villeneuve E, Gosselin S. Massive acetaminophen overdose: effect of hemodialysis on acetaminophen and acetylcysteine kinetics. Clin Toxicol. 2016 Jul 2;54(6):519-522. doi:10.1080/15563650.2016.1175006. https://pubmed.ncbi.nlm.nih.gov/27118496/
18. Akakpo JY, Ramachandran A, Curry SC, Rumack BH, Jaeschke H. Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose. Arch Toxicol. 2022 Feb 3;96(2):453-465. doi:10.1007/s00204-021-03211-z. https://pubmed.ncbi.nlm.nih.gov/34978586/
19. Gosselin S, Juurlink DN, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, et al. Extracorporeal treatment for acetaminophen poisoning: Recommendations from the EXTRIP workgroup. Clin Toxicol. 2014 Sep 18;52(8):856-867. doi:10.3109/15563650.2014.946994. https://pubmed.ncbi.nlm.nih.gov/25133498/